Except for the groups treated with PPi, the aortic mRNA expression of type III sodium-dependent phosphate transporter 1 (Pit-1) significantly increased in the presence of CKD, while expression of Pit-2 in the presence of CKD significantly decreased. The gene discussed is SLC20A2; the disease is chronic kidney disease.